Bioventus Inc.BVSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank62
3Y CAGR-0.2%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-0.2%/yr
vs -25.4%/yr prior
Acceleration
+25.2pp
Accelerating
Percentile
P62
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 79.45% |
| Q3 2025 | -34.10% |
| Q2 2025 | 277.24% |
| Q1 2025 | -39.05% |
| Q4 2024 | 96.07% |
| Q3 2024 | 112.94% |
| Q2 2024 | -738.66% |
| Q1 2024 | 323.00% |
| Q4 2023 | -51.82% |
| Q3 2023 | -64.18% |
| Q3 2023 | 107.33% |
| Q2 2023 | -261.93% |
| Q4 2022 | 79.95% |
| Q4 2022 | -3734.31% |
| Q3 2022 | 84.58% |
| Q2 2022 | -580.95% |
| Q4 2021 | -200.86% |
| Q4 2021 | 81.76% |
| Q3 2021 | -126.09% |
| Q2 2021 | 272.34% |
| Q4 2020 | -14.78% |
| Q3 2020 | 250.95% |
| Q2 2020 | -135.36% |
| Q1 2020 | -5.21% |
| Q4 2019 | 29.21% |
| Q3 2019 | 207.57% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2015 | 0.00% |